Aytu Biopharma (AYTU) Research & Development (2014 - 2025)
Aytu Biopharma's Research & Development was $216,000 in fiscal Q4 2025 (quarter ended Jun 30, 2025), down 79.3% from $1.04 million a year earlier but up 33.3% from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Research & Development (2014 - 2025) Analysis & Trends
For FY2025 (ended Jun 30, 2025), Research & Development at Aytu Biopharma came in at $1.33 million, down 52.1% from FY2024.
- Research & Development has now declined for three consecutive fiscal years, with a five-year compound annual growth rate of -5.1% (FY2020 to FY2025).
- In earlier fiscal years, Research & Development was $2.77 million in FY2024 (-32.4%), $4.1 million in FY2023 (-67.7%), $12.66 million in FY2022 (+125.2%) and $5.62 million in FY2021 (+226.5%).
- Quarterly Research & Development has moved between $162,000 (fiscal Q3 2025) and $4.76 million (fiscal Q4 2021) over five years.
- Compared with a year earlier, Research & Development was higher in two of the last eight quarters, with an average decline of 24.9%.
- The best year-over-year quarter for Research & Development over five years was fiscal Q1 2022 (growth of 802.7%); the worst was fiscal Q4 2023 (a decline of 85.7%).
- Per Business Quant data, AYTU's Research & Development in the three fiscal quarters before Q4 2025 was $162,000 (Q3 2025), $522,000 (Q2 2025) and $426,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Aytu Biopharma | 23.58 Mn | -92.10 Mn | 10.41 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 216,000.00 |
| Mar 31, 2025 | 162,000.00 |
| Dec 31, 2024 | 522,000.00 |
| Sep 30, 2024 | 426,000.00 |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | 611,000.00 |
| Dec 31, 2023 | 521,000.00 |
| Sep 30, 2023 | 595,000.00 |
| Jun 30, 2023 | 465,000.00 |
| Mar 31, 2023 | 856,000.00 |
| Dec 31, 2022 | 1.71 Mn |
| Sep 30, 2022 | 1.06 Mn |
| Jun 30, 2022 | 3.25 Mn |
| Mar 31, 2022 | 3.28 Mn |
| Dec 31, 2021 | 4.48 Mn |
| Sep 30, 2021 | 1.65 Mn |
| Jun 30, 2021 | 4.76 Mn |
| Mar 31, 2021 | 390,000.00 |
| Dec 31, 2020 | 286,000.00 |
| Sep 30, 2020 | 183,000.00 |
API Access
Aytu Biopharma Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();